Specific protein degradation is being explored instead method in cancer, whereby the natural protein degradation process is co-opted for therapeutic reasons. Not too long ago made novel molecules named proteolysis-targeting chimeras (PROTACs) are heterobifunctional molecules with two ligands joined by a linker. A person ligand binds into the ‘protein of https://www.directivepublications.org/journal-of-clinical-breast-cancer/